Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Antonis C. Antoniou(Weatherford College), Eitan Friedman(University of Pennsylvania), Kati Kämpjärvi(Helsinki University Hospital), Fergus J. Couch(Mayo Clinic), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Jeffrey N. Weitzel(Cancer Genetics (United States)), Karen A. Pooley(University of Cambridge), Christoph Engel(University Hospital Leipzig), Flavio Lejbkowicz(Carmel Medical Center), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Theresa Wagner(Fox Chase Cancer Center), Bella Kaufman(NYU Langone Health), Irene L. Andrulis(University of Toronto), Gail E. Tomlinson(Urology San Antonio), Olufunmilayo I. Olopade(University of Chicago), Csilla I. Szabo(University of Delaware), Jacques Simard(Université Laval), Heli Nevanlinna(University of Helsinki), Norbert Arnold(Christian-Albrechts-Universität zu Kiel), Susan L. Neuhausen(City of Hope), Christian Sutter(Heidelberg University), Claudine Isaacs(Georgetown University), Anne‐Marie Gerdes(Copenhagen University Hospital), Roni Milgrom(Sheba Medical Center), Dieter Niederacher(Heinrich Heine University Düsseldorf), Beatrix Versmold(University Hospital Cologne), Gad Rennert(Technion – Israel Institute of Technology), Mark H. Greene(Cancer Institute (WIA)), Wera Hofmann(Charité - Universitätsmedizin Berlin), Jonathan Beesley(The University of Melbourne), Joanne L. Blum(Brigham and Women's Hospital), Patricia A. Ganz(Los Angeles County Department of Public Health), Paolo Peterlongo(IFOM), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Paolo Radice(IFOM), Monica Barile(European Institute of Oncology), Hilmi Özçelik(Mount Sinai Hospital), Yael Laitman(Sheba Medical Center), Mary B. Daly(Fox Chase Cancer Center), Sue Healey(QIMR Berghofer Medical Research Institute), Timothy R. Rebbeck(University of Pennsylvania), Rita K. Schmutzler(The University of Melbourne), Henry T. Lynch(Creighton University), Olga M. Sinilnikova(Hospices Civils de Lyon), Helmut Deißler(Universität Ulm), Alfons Meindl(Helmholtz Zentrum München), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Lutécia H. Mateus Pereira(National Institutes of Health), Ofra Barnett‐Griness(Carmel Medical Center)
Cited by 284
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Mutation of a <i>mutL</i> Homolog in Hereditary Colon Cancer
|Science|1994|1.8k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k